Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v6-FR
Language English French
Date Updated 2025-12-05 2025-12-04
Drug Identification Number 02330407 02330407
Brand name CLOLAR CLOLAR
Common or Proper name clofarabine clofarabine
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients CLOFARABINE CLOFARABINE
Strength(s) 1MG 1MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 1 1
ATC code L01BB L01BB
ATC description ANTIMETABOLITES ANTIMETABOLITES
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2025-11-01 2025-11-01
Actual start date 2025-11-01 2025-11-01
Estimated end date
Actual end date 2025-12-04 2025-12-04
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Supply Delay The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy. Supply Delay The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments